Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)
Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –
Utah Medical Products operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Utah Medical Products's operating cash flow for the twelve months ending Jun 30, 2026 was $11.85M. For fiscal 2025 it was $14.69M, down 0.9% from the year before. Over ten years it grew 0.6% a year on average. The highest annual figure on record is $22.28M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.69M | -0.9% |
| FY2024 | Dec 31, 2024 | $14.83M | -33.4% |
| FY2023 | Dec 31, 2023 | $22.28M | +5.4% |
| FY2022 | Dec 31, 2022 | $21.15M | -0.3% |
| FY2021 | Dec 31, 2021 | $21.20M | +5.3% |
| FY2020 | Dec 31, 2020 | $20.14M | +18.1% |
| FY2019 | Dec 31, 2019 | $17.06M | +1.3% |
| FY2018 | Dec 31, 2018 | $16.83M | -0.4% |
| FY2017 | Dec 31, 2017 | $16.91M | +16.4% |
| FY2016 | Dec 31, 2016 | $14.53M | +5.3% |
| FY2015 | Dec 31, 2015 | $13.80M | -10.3% |
| FY2014 | Dec 31, 2014 | $15.39M | +25.0% |
| FY2013 | Dec 31, 2013 | $12.31M | -9.3% |
| FY2012 | Dec 31, 2012 | $13.56M | +19.3% |
| FY2011 | Dec 31, 2011 | $11.37M | +58.8% |
| FY2010 | Dec 31, 2010 | $7.16M | -1.0% |
| FY2009 | Dec 31, 2009 | $7.23M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.38M | -51.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.11M | -30.4% |
| Q4 FY2025 | Dec 31, 2025 | $3.48M | -34.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.88M | -24.3% |
| Q2 FY2025 | Jun 30, 2025 | $2.87M | -41.5% |
| Q1 FY2025 | Mar 31, 2025 | $4.46M | -35.4% |
| Q4 FY2023 | Dec 31, 2023 | $5.33M | -6.1% |
| Q3 FY2023 | Sep 30, 2023 | $5.12M | -8.4% |
| Q2 FY2023 | Jun 30, 2023 | $4.91M | +1.7% |
| Q1 FY2023 | Mar 31, 2023 | $6.92M | +37.0% |
| Q4 FY2022 | Dec 31, 2022 | $5.68M | +13.9% |
| Q3 FY2022 | Sep 30, 2022 | $5.59M | -6.7% |
| Q2 FY2022 | Jun 30, 2022 | $4.83M | +3.0% |
| Q1 FY2022 | Mar 31, 2022 | $5.05M | -8.8% |
| Q4 FY2021 | Dec 31, 2021 | $4.99M | -13.7% |
| Q3 FY2021 | Sep 30, 2021 | $5.99M | +19.6% |
| Q2 FY2021 | Jun 30, 2021 | $4.69M | +27.6% |
| Q1 FY2021 | Mar 31, 2021 | $5.53M | -2.5% |
| Q4 FY2020 | Dec 31, 2020 | $5.78M | +2.4% |
| Q3 FY2020 | Sep 30, 2020 | $5.01M | -21.4% |
| Q2 FY2020 | Jun 30, 2020 | $3.68M | +118.5% |
| Q1 FY2020 | Mar 31, 2020 | $5.67M | +68.9% |
| Q4 FY2019 | Dec 31, 2019 | $5.64M | +25.8% |
| Q3 FY2019 | Sep 30, 2019 | $6.37M | +38.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.68M | -57.7% |
| Q1 FY2019 | Mar 31, 2019 | $3.36M | -10.8% |
| Q4 FY2018 | Dec 31, 2018 | $4.48M | -2.2% |
| Q3 FY2018 | Sep 30, 2018 | $4.60M | +0.5% |
| Q2 FY2018 | Jun 30, 2018 | $3.98M | +15.9% |
| Q1 FY2018 | Mar 31, 2018 | $3.77M | -12.6% |
| Q4 FY2017 | Dec 31, 2017 | $4.59M | +35.5% |
| Q3 FY2017 | Sep 30, 2017 | $4.58M | +35.6% |
| Q2 FY2017 | Jun 30, 2017 | $3.44M | -4.9% |
| Q1 FY2017 | Mar 31, 2017 | $4.31M | +3.7% |
| Q4 FY2016 | Dec 31, 2016 | $3.39M | -13.3% |
| Q3 FY2016 | Sep 30, 2016 | $3.38M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.61M | – |
| Q1 FY2016 | Mar 31, 2016 | $4.15M | – |
| Q4 FY2015 | Dec 31, 2015 | $3.91M | – |
See a number that looks wrong?